Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07714057
Recruiting Not applicable

Effect of Hydrogen-rich Water During Tapering on Recovery After Functional Overreaching in Basketball Players

NCT07714057 · tracked via the Priya Life Science Czechia tracker
Phase
Not applicable
Started
2026-07-27
Last updated
2026-07-28

Condition(s) studied

Healthy Active Athletes

Investigational drug(s) / intervention(s)

Hydrogen-rich waterPlacebo water

Hydrogen-rich water: Hydrogen-rich water with molecular hydrogen concentration \>1.0 ppm.

Placebo water: Tap water without molecular hydrogen.

Study summary

The goal of this clinical trial is to evaluate whether hydrogen-rich water supplementation during tapering improves recovery after functional overreaching in competitive male basketball players aged 18-35 years. The main questions it aims to answer are:

* Does hydrogen-rich water improve autonomic recovery after functional overreaching?
* Does hydrogen-rich water improve recovery in biochemical, performance, and subjective feeling outcomes during tapering?

Researchers will compare hydrogen-rich water to placebo (water containing no molecular hydrogen) to determine whether molecular hydrogen improves recovery after accumulated fatigue has been induced by functional overreaching. Participants will:

* Complete a training cycle including normal training, functional overreaching, and tapering.
* Consume hydrogen-rich or placebo water daily during the one-week tapering period.
* Undergo repeated testing of autonomic nervous system, blood biochemical markers, performance, and subjective soreness.

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Competitive male basketball players. * Signed informed consent. * Completion of entry medical and laboratory screening. Exclusion Criteria: * Acute injury or infection. * History or presence of relevant cardiovascular, respiratory, metabolic, or other disease that may affect the study results. * Use of medication affecting recovery markers or study results.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Palacky University, Faculty of Physical Culture Olomouc Czechia Recruiting

More Palacky University trials in Czechia

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07714057 on ClinicalTrials.gov ↗ ← All trials in Czechia